Reardon Andrew
CIK 1950232
Transactions on file
62
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-02 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 17 | $5.2K | -1.4% | open → |
| 2026-10-06 | 2026-10-02 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 235 | $72.2K | -1.2% | open → |
| 2026-10-06 | 2026-10-02 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 404 | $123.7K | -0.9% | open → |
| 2026-10-06 | 2026-10-02 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,535 | $467.4K | -0.3% | open → |
| 2026-10-06 | 2026-10-02 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,976 | $599.8K | -0.0% | open → |
| 2026-10-06 | 2026-10-02 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 833 | $252.0K | +0.3% | open → |
| 2026-10-06 | 2026-10-02 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Exer. | 340 | $17.8K | +480.7% | open → |
| 2026-09-08 | 2026-09-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 400 | $115.6K | +5.0% | open → |
| 2026-09-08 | 2026-09-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 385 | $110.7K | +5.6% | open → |
| 2026-09-08 | 2026-09-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 2,115 | $605.6K | +6.0% | open → |
| 2026-09-08 | 2026-09-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,800 | $513.3K | +6.4% | open → |
| 2026-09-08 | 2026-09-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 300 | $85.2K | +6.9% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 409 | $119.8K | +3.7% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 991 | $289.1K | +4.1% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 200 | $58.1K | +4.4% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 503 | $145.8K | +4.7% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 356 | $102.8K | +5.1% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,214 | $349.4K | +5.5% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,032 | $296.0K | +5.8% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 157 | $44.9K | +6.2% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 33 | $9.4K | +6.7% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 105 | $29.8K | +6.8% | open → |
| 2026-08-04 | 2026-08-03 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Exer. | 5,000 | $261.4K | +480.7% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 600 | $190.3K | -4.3% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 900 | $284.2K | -3.9% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 100 | $31.5K | -3.5% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 700 | $219.4K | -3.2% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,081 | $337.6K | -2.8% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,119 | $348.8K | -2.6% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 104 | $32.3K | -2.2% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 396 | $122.4K | -1.8% | open → |
| 2026-07-06 | 2026-07-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Exer. | 5,000 | $261.4K | +480.7% | open → |
| 2026-07-06 | 2026-06-30 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Other | 132 | $21.2K | +88.9% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 200 | $46.1K | +31.7% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,216 | $279.0K | +32.3% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 584 | $133.5K | +32.8% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 400 | $90.7K | +33.8% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,432 | $323.6K | +34.3% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 677 | $152.5K | +34.8% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 491 | $110.0K | +35.5% | open → |
| 2026-06-02 | 2026-06-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Exer. | 5,000 | $261.4K | +480.7% | open → |
| 2025-02-19 | 2025-02-15 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Tax | 1,114 | $133.7K | +152.9% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Grant | 6,928 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Tax | 2,775 | $333.0K | +152.9% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Grant | 5,429 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-15 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Tax | 876 | $105.1K | +152.9% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Tax | 1,758 | $211.0K | +152.9% | open → |
| 2025-03-06 | 2025-03-04 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Grant | 6,415 | $0.00 | — | open → |
| 2025-06-02 | 2024-08-10 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Tax | 897 | $89.8K | +203.0% | open → |
| 2025-06-02 | 2025-05-15 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,000 | $104.0K | +191.9% | open → |
| 2025-06-12 | 2025-06-10 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 500 | $57.3K | +165.0% | open → |
| 2025-06-24 | 2025-06-23 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 500 | $57.0K | +166.1% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 800 | $187.2K | +29.7% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 1,420 | $330.7K | +30.3% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 780 | $181.0K | +30.8% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 370 | $85.4K | +31.5% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 98 | $22.5K | +32.1% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 932 | $213.2K | +32.7% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Sale | 600 | $136.5K | +33.4% | open → |
| 2026-05-05 | 2026-05-01 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Exer. | 5,000 | $261.4K | +480.7% | open → |
| 2025-07-02 | 2025-06-30 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Other | 233 | $21.2K | +233.3% | open → |
| 2025-08-12 | 2025-08-10 | LGND LIGAND PHARMACEUTICALS INC | Officer CLO & Secretary | Tax | 1,325 | $198.8K | +102.3% | open → |
